Chromosome studies in acute promyelocytic leukemia. An analysis of 11 cases

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

ESMO open·2024

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

Frontiers in pharmacology·2023

Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma.

Blood cancer journal·2022

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Leukemia·2020

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.

Journal of experimental & clinical cancer research : CR·2019

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.

Haematologica·2026

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Haematologica·2026

Protecting sickle cell care during Ebola outbreaks.

Haematologica·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Haematologica·2026

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era.

Haematologica·2026

Whole-genome sequencing identifies a potentially causative homozygous splicing variant in RAD54 like in non-obstructive azoospermia.

International journal of reproductive biomedicine·2026

FAN1 mutation and karyomegalic nephropathy in chronic kidney disease.

BMJ case reports·2026

The Quasi-Systematic Nature of Splitter Cells.

Neural computation·2026

Chromosome Editing Using the Lambda Red Recombinase System in Chlamydia trachomatis and Chlamydia muridarum.

Methods in molecular biology (Clifton, N.J.)·2026

Decoding cell division history and lineage-resolved phenotypic patterns from single-cell barcode and transcriptomic data.

Genome research·2026

Spatial genome organization in nematodes with programmed DNA elimination.

Genome research·2026

Related Experiment Videos

Chromosome studies in acute promyelocytic leukemia. An analysis of 11 cases

Related Concept Videos

High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT.

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma.

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.

Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).

Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Protecting sickle cell care during Ebola outbreaks.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era.

Whole-genome sequencing identifies a potentially causative homozygous splicing variant in RAD54 like in non-obstructive azoospermia.

FAN1 mutation and karyomegalic nephropathy in chronic kidney disease.

The Quasi-Systematic Nature of Splitter Cells.

Chromosome Editing Using the Lambda Red Recombinase System in Chlamydia trachomatis and Chlamydia muridarum.

Decoding cell division history and lineage-resolved phenotypic patterns from single-cell barcode and transcriptomic data.

Spatial genome organization in nematodes with programmed DNA elimination.

Related Experiment Videos

Chromosome studies in acute promyelocytic leukemia. An analysis of 11 cases

Related Concept Videos

Related Articles